One of the leading US companies working on a coronavirus vaccine has signed a deal seeking to manufacture 1 billion doses a year.
Read the full article here.
This content was originally published by Fin24 News. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Fin24 News